France – Produits pharmaceutiques – 26-10 : ACCORD-CADRE DE FOURNITURE DE MÉDICAMENTS 2026
AI summary
This tender concerns a framework agreement for the supply of pharmaceuticals in 2026. The contracting authority GCS HACOM seeks qualified suppliers to provide a range of medicinal products to support healthcare delivery across the organization.
Pharmaceutical suppliers, distributors, or manufacturers authorized to operate in France and capable of meeting healthcare sector supply requirements should submit proposals.
Suppliers must be authorized pharmaceutical distributors or manufacturers with the ability to supply medicinal products in compliance with French and European pharmaceutical regulations. They should demonstrate reliable delivery capacity and quality assurance systems.
Frequently asked questions
What is this tender about?
This tender concerns a framework agreement for the supply of pharmaceuticals in 2026. The contracting authority GCS HACOM seeks qualified suppliers to provide a range of medicinal products to support healthcare delivery across the organization.
What are the requirements for suppliers?
Suppliers must be authorized pharmaceutical distributors or manufacturers with the ability to supply medicinal products in compliance with French and European pharmaceutical regulations. They should demonstrate reliable delivery capacity and quality assurance systems.
What type of company should bid?
Pharmaceutical suppliers, distributors, or manufacturers authorized to operate in France and capable of meeting healthcare sector supply requirements should submit proposals.
Who is the buyer?
The buyer is GCS HACOM.
When does this tender close?
Submissions close on August 21, 2026.
What is the estimated value?
The estimated value is 0 EUR.
26-10 : ACCORD-CADRE DE FOURNITURE DE MÉDICAMENTS 2026
A06AD11 - LAXATIF OSMOTIQUE SUCRE OU POLYOL FORME BUVABLE
A10BB09 - GLICLAZIDE FAIBLE DOSAGE FORME ORALE LIBERATION MODIFIEE
A16AX06 - MIGLUSTAT FORME ORALE
B01AF01 - RIVAROXABAN 2,5 MG FORME ORALE
B05XA03 - NACL 0,9% INJECTABLE AMPOULE PLASTIQUE 10 ET 20 ML
B05XA03 - NACL 10% INJECTABLE AMPOULE PLASTIQUE 10 ET 20 ML
B05XA03 - NACL 20% INJECTABLE AMPOULE PLASTIQUE 10 ET 20 ML
C08DB01 - DILTIAZEM FORT DOSAGE FORME ORALE LIBERATION PROLONGEE
C09BA05 - RAMIPRIL + HYDROCHLOROTHIAZIDE FORME ORALE
CO2KX01- BOSENTAN 32 MG FORME ORALE
H02AB02 - DEXAMETHASONE INJECTABLE
H02AB04 - METHYLPREDNISOLONE INJECTABLE FAIBLE DOSAGE
H02AB04 - METHYLPREDNISOLONE MOYEN DOSAGE INJECTABLE
H02AB04 - METHYLPREDNISOLONE FORT DOSAGE INJECTABLE
J01GB06 - AMIKACINE FORT DOSAGE INJECTABLE
J01XA04 - DALBAVANCINE INJECTABLE
J02AA01 - AMPHOTERICINE B liposomal
J05AF06 - ABACAVIR
J07AH08 - VACCIN MENINGOCOQUE ACYW A PARTIR D'1 AN
J07AH08 - VACCIN MENINGOCOQUE ACYW ENFANT < à 1 an
J07AH09 - VACCIN MENINGOCOQUE B A PARTIR DE 10 ans
J07AH09 - VACCIN MENINGOCOQUE B ENFANT < 10 ans
J07AL02 - VACCIN PNEUMOCOQUE ADULTE
J07AL02 - VACCIN PNEUMOCOQUE PEDIATRIQUE
L01BC07 - AZACITIDINE
L01CX01 - TRABECTEDINE
L01DB03 - EPIRUBICINE 100 MG INJECTABLE
L01DC03 - MITOMYCINE
L01EX09 - NINTEDANIB
L04AX06 - POMALIDOMIDE FORME ORALE
N02BG06 - NEFOPAM INJECTABLE
N07XX04 - OXYBATE DE SODIUM FORME BUVABLE
S01ED - COLLYRE PROSTAGLANDINE FLACON
S01LA05 - AFLIBERCEPT
V03AB25 - FLUMAZENIL INJECTABLE
V07AB - EAU POUR PREPARATION INJECTABLE AMPOULE PLASTIQUE 5 ET 20 ML
- PriceCritère Prix35%
- QualityCritère de Qualité Technique45%
- QualityCritère de Notation fournisseur via questionnaire Logistique/Prestations20%
Computing match…
AI document analysis
We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.
Loading…